Skip to content

Application and Safety Evaluation of Saline-Coupled Bipolar Radiofrequency Systems in the Treatment of Bone Tumors

Application and Safety Evaluation of Saline-Coupled Bipolar Radiofrequency Systems in the Treatment of Bone Tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115202
Enrollment
Unknown
Registered
2025-12-23
Start date
2025-06-30
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Bone Tumors(Enchondroma

Interventions

Saline-Coupled Bipolar Radiofrequency System Group:None
Control Group (Conventional Electrocautery Group):None

Sponsors

The Third Affiliated Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Diagnosed with benign bone tumors (enchondroma, chondroblastoma, osteoid osteoma, osteoma, aneurysmal bone cyst, non-ossifying fibroma, fibrous dysplasia of bone) or intermediate (locally aggressive/borderline) bone tumors (atypical cartilaginous tumor, osteoblastoma, giant cell tumor of bone) according to the WHO Classification of Bone Tumors (2020 Edition); 2.Patients treated at The Third Affiliated Hospital of Southern Medical University between January 2016 and January 2024; 3.First-time recipients of curettage surgery for the lesion; 4.Tumors located exclusively in the extremities;

Exclusion criteria

Exclusion criteria: 1.History of non-musculoskeletal malignancy within the past 5 years; 2.Concurrent metastatic bone tumors or malignant transformation; 3.Prior chemotherapy, radiotherapy, or targeted therapy before surgery; 4.Critical data missing (e.g., incomplete surgical records, loss to follow-up); 5.Inability to comply with study requirements, including completion of follow-up visits or adherence to protocol-specified procedures (e.g., clinical outcome assessments), as judged by the investigator or subject; 6.Unstable systemic diseases, including active infection, uncontrolled hypertension, unstable angina, congestive heart failure, or myocardial infarction; 7.Other conditions deemed ineligible for participation by the investigator (e.g., atypical clinical presentation or high surgical risk);

Design outcomes

Primary

MeasureTime frame
Local recurrence and/or metastasis;Recurrence-free survival;Recurrence rate;

Secondary

MeasureTime frame
Incidence of Various Postoperative Complications;Occurrence Time;

Countries

China

Contacts

Public ContactHaomiao Li

The Third Affiliated Hospital of Southern Medical University

lihaomiao1977@hotmail.com+86 20 62784553

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026